Results 141 to 150 of about 26,409 (219)

Central nervous system efficacy of furmonertinib (AST2818) in patients with EGFR T790M mutated non-small cell lung cancer: a pooled analysis from two phase 2 studies. [PDF]

open access: yesBMC Med, 2023
Hu X   +29 more
europepmc   +1 more source

Central nervous system efficacy of aumolertinib versus gefitinib in patients with untreated, EGFR-mutated, advanced non-small cell lung cancer: data from a randomized phase III trial (AENEAS). [PDF]

open access: yesCancer Commun (Lond)
Lu S   +56 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy